Delcath Systems Debt to Equity Ratio 2010-2024 | DCTH
Current and historical debt to equity ratio values for Delcath Systems (DCTH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Delcath Systems debt/equity for the three months ending June 30, 2024 was 0.00.
| Delcath Systems Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-06-30 | $0.03B | $0.00B | 7.09 |
| 2024-03-31 | $0.02B | $0.02B | 1.47 |
| 2023-12-31 | $0.02B | $0.02B | 1.45 |
| 2023-09-30 | $0.02B | $0.03B | 0.93 |
| 2023-06-30 | $0.02B | $0.00B | -87.98 |
| 2023-03-31 | $0.04B | $-0.01B | -3.34 |
| 2022-12-31 | $0.02B | $-0.01B | -4.05 |
| 2022-09-30 | $0.03B | $-0.01B | -4.86 |
| 2022-06-30 | $0.02B | $-0.00B | -8.40 |
| 2022-03-31 | $0.02B | $0.01B | 4.23 |
| 2021-12-31 | $0.02B | $0.01B | 1.77 |
| 2021-09-30 | $0.02B | $0.01B | 1.94 |
| 2021-06-30 | $0.01B | $0.02B | 0.64 |
| 2021-03-31 | $0.01B | $0.02B | 0.62 |
| 2020-12-31 | $0.01B | $0.02B | 0.57 |
| 2020-09-30 | $0.01B | $0.00B | 4.06 |
| 2020-06-30 | $0.01B | $0.01B | 1.65 |
| 2020-03-31 | $0.02B | $-0.01B | -2.22 |
| 2019-12-31 | $0.02B | $-0.01B | -3.24 |
| 2019-09-30 | $0.04B | $-0.02B | -2.00 |
| 2019-06-30 | $0.04B | $-0.03B | -1.19 |
| 2019-03-31 | $0.03B | $-0.02B | -1.26 |
| 2018-12-31 | $0.02B | $-0.02B | -1.46 |
| 2018-09-30 | $0.02B | $-0.01B | -3.64 |
| 2018-06-30 | $0.02B | $-0.01B | -1.42 |
| 2018-03-31 | $0.01B | $-0.01B | -2.04 |
| 2017-12-31 | $0.01B | $0.00B | 12.11 |
| 2017-09-30 | $0.02B | $-0.00B | -8.83 |
| 2017-06-30 | $0.02B | $0.00B | 20.46 |
| 2017-03-31 | $0.03B | $-0.00B | -53.97 |
| 2016-12-31 | $0.04B | $-0.00B | -24.65 |
| 2016-09-30 | $0.03B | $0.00B | 7.24 |
| 2016-06-30 | $0.04B | $0.01B | 6.62 |
| 2016-03-31 | $0.01B | $0.01B | 0.59 |
| 2015-12-31 | $0.01B | $0.01B | 0.83 |
| 2015-09-30 | $0.01B | $0.01B | 0.45 |
| 2015-06-30 | $0.00B | $0.01B | 0.33 |
| 2015-03-31 | $0.01B | $0.02B | 0.32 |
| 2014-12-31 | $0.01B | $0.02B | 0.31 |
| 2014-09-30 | $0.01B | $0.02B | 0.30 |
| 2014-06-30 | $0.01B | $0.03B | 0.24 |
| 2014-03-31 | $0.01B | $0.03B | 0.22 |
| 2013-12-31 | $0.01B | $0.03B | 0.23 |
| 2013-09-30 | $0.01B | $0.03B | 0.19 |
| 2013-06-30 | $0.01B | $0.03B | 0.16 |
| 2013-03-31 | $0.01B | $0.04B | 0.29 |
| 2012-12-31 | $0.01B | $0.02B | 0.52 |
| 2012-09-30 | $0.01B | $0.03B | 0.40 |
| 2012-06-30 | $0.01B | $0.02B | 0.63 |
| 2012-03-31 | $0.01B | $0.02B | 0.53 |
| 2011-12-31 | $0.01B | $0.03B | 0.35 |
| 2011-09-30 | $0.01B | $0.04B | 0.21 |
| 2011-06-30 | $0.01B | $0.02B | 0.47 |
| 2011-03-31 | $0.02B | $0.03B | 0.51 |
| 2010-12-31 | $0.02B | $0.03B | 0.74 |
| 2010-09-30 | $0.02B | $0.04B | 0.36 |
| 2010-06-30 | $0.01B | $0.02B | 0.78 |
| 2010-03-31 | $0.02B | $0.01B | 1.99 |
| 2009-12-31 | $0.01B | $0.02B | 0.55 |
| 2009-09-30 | $0.01B | $-0.01B | -2.37 |
| 2009-06-30 | $0.01B | $0.00B | 3.49 |
| 2009-03-31 | $0.00B | $0.01B | 0.16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.304B | $0.002B |
| Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.078B | 26.12 |
| Intuitive Surgical (ISRG) | United States | $183.628B | 96.01 |
| Alcon (ALC) | Switzerland | $45.117B | 31.76 |
| IQVIA Holdings (IQV) | United States | $40.157B | 22.12 |
| Edwards Lifesciences (EW) | United States | $39.608B | 24.62 |
| IDEXX Laboratories (IDXX) | United States | $34.672B | 40.83 |
| DexCom (DXCM) | United States | $26.799B | 40.36 |
| Waters (WAT) | United States | $22.960B | 33.95 |
| STERIS (STE) | Ireland | $22.437B | 25.85 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.922B | 0.00 |
| Hologic (HOLX) | United States | $18.696B | 19.73 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.376B | 12.70 |
| Sysmex ADR (SSMXY) | Japan | $11.851B | 37.16 |
| Globus Medical (GMED) | United States | $11.200B | 28.52 |
| Teleflex (TFX) | United States | $9.378B | 14.96 |
| Penumbra (PEN) | United States | $8.969B | 87.86 |
| Masimo (MASI) | United States | $8.917B | 43.43 |
| Glaukos (GKOS) | United States | $7.755B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.126B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.542B | 25.75 |
| Inari Medical (NARI) | United States | $3.119B | 0.00 |
| TransMedics (TMDX) | United States | $2.898B | 91.86 |
| LivaNova (LIVN) | United Kingdom | $2.829B | 16.33 |
| Veracyte (VCYT) | United States | $2.811B | 85.09 |
| Nihon Kohden (NHNKY) | Japan | $2.519B | 15.68 |
| Tandem Diabetes Care (TNDM) | United States | $2.242B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.227B | 18.14 |
| Integra LifeSciences Holdings (IART) | United States | $2.060B | 10.77 |
| RxSight (RXST) | United States | $2.024B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.257B | 0.00 |
| Artivion (AORT) | United States | $1.233B | 113.23 |
| Pulse Biosciences (PLSE) | United States | $1.110B | 0.00 |
| OPKO Health (OPK) | United States | $1.025B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.963B | 16.37 |
| OrthoPediatrics (KIDS) | United States | $0.749B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.726B | 18.33 |
| Pacific Biosciences Of California (PACB) | United States | $0.722B | 0.00 |
| IRadimed (IRMD) | United States | $0.712B | 38.49 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.702B | 0.00 |
| AxoGen (AXGN) | United States | $0.672B | 0.00 |
| SiBone (SIBN) | United States | $0.669B | 0.00 |
| Paragon 28 (FNA) | United States | $0.605B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.485B | 0.00 |
| CVRx (CVRX) | United States | $0.374B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.369B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.99 |
| AngioDynamics (ANGO) | United States | $0.301B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.291B | 19.57 |
| Sight Sciences (SGHT) | United States | $0.257B | 0.00 |
| NeuroPace (NPCE) | United States | $0.228B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Nevro (NVRO) | United States | $0.216B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.186B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| 908 Devices (MASS) | United States | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 16.32 |
| EDAP TMS S.A (EDAP) | France | $0.105B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| LENSAR (LNSR) | United States | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.061B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.051B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.049B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.038B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.028B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.019B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |